Particle.news

Download on the App Store

Small Subset of Newborn Liver Cells Drives Growth, Recasting Pediatric Gene Therapy Timing

Peer‑reviewed mouse data identify clonogenic hepatocytes as the key growth engine guiding pediatric liver gene therapy design.

Overview

  • Only 15–20% of hepatocytes in newborn mice clonally expand to generate more than 90% of the adult liver mass.
  • Homology-directed repair editing is enriched in these clonogenic cells, increasing the edited liver area as the organ grows.
  • Lentiviral delivery becomes less permissive after weaning with the rise of peri-central identity and proteasome activity, but pretreatment with a proteasome inhibitor restored adult hepatocyte transduction.
  • Single-cell and spatial transcriptomics, clonal tracing, and mathematical modeling mapped the cells’ molecular identities and a neonatal niche adjacent to hematopoietic progenitors.
  • The Journal of Hepatology study from SR‑Tiget and collaborators outlines preclinical principles for timing, vector choice, and adjunct pharmacology, with ERC-backed follow-up work planned.